z-logo
open-access-imgOpen Access
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
Author(s) -
Cagri Gultekin,
Ahmet Özer Şehirli,
Şule Çetınel,
Serkan Sayıner
Publication year - 2022
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2022_060
Subject(s) - ambroxol , ischemia , medicine , reperfusion injury , proinflammatory cytokine , pharmacology , hepatocyte , anesthesia , tumor necrosis factor alpha , inflammation , chemistry , biochemistry , in vitro
The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here